Is pediatric labeling really necessary?

Pediatrics

Volumn 104, Issue 3 II, 1999, Pages 593-597

  Christensen, Michael L ^a   Helms, Richard A ^a   Chesney, Russell W ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Department of Pediatrics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BENZYL ALCOHOL; CHLORAMPHENICOL; MULTIVITAMIN; POLYSORBATE 20; POLYSORBATE 80; PROPYLENE GLYCOL; SULFANILAMIDE; THALIDOMIDE;

CHILD CARE; CONFERENCE PAPER; DOSE CALCULATION; DRUG APPROVAL; DRUG EFFICACY; DRUG ELIMINATION; DRUG LABELING; DRUG LEGISLATION; DRUG METABOLISM; DRUG RESEARCH; DRUG SAFETY; FETUS MALFORMATION; KERNICTERUS; LIVER METABOLISM; LIVER TOXICITY; PRESCRIPTION; PRIORITY JOURNAL; STANDARD; TREATMENT FAILURE; UNITED STATES;

EID: 0032886560     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Gilman JT, Gal P. Pharmacokinetic and pharmacodynamic data collection in children and neonates. Clin Pharmacokinet. 1992;23:1-9
2. Deaths due to elixir of sulfanilamide-Massengill: report of the Secretary of Agriculture submitted to House Resolution 352 of November 19, 1937 and Senate Resolution of November 16, 1937. JAMA. 1937; 109: 1985-1988
3. Lenz W. A study of the German outbreak of phocomelia. Lancet. 1962; 2:1332
4. Taussig H. A study of the German outbreak of phocomelia. JAMA. 1962;198:1106-14
5. 21 Code of Federal Regulation (CFR) 201.57(f)(9)
6. Burns LE, Hodgman JE, Cass AB. Fatal circulatory collapse in premature infants receiving chloramphenicol. N Engl J Med. 1959;261: 1318-1321
7. Sutherland JM. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. Am J Dis Child. 1959;97:761
8. Silverman WA, Andersen DH, Blanc WA, Crozier DN. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics. 1956;18: 614
9. Lorch V, Murphy D, Hoersten LR, Harris E, Fitzgerald J, Sinha SN. Unusual syndrome among premature infants; association with a new intravenous vitamin E product. Pediatrics. 1985;75:598-602
10. Bove KE, Kosmetatos N, Wedig KE, et al. Vasculopathic hepatotoxicity associated with E-ferol syndrome in low-birth weight-infants. JAMA. 1985;254:2422-2430
11. Glasgow AM, Boechx RL, Miller MK, MacDonald MG, August GP, Goodman SI. Hyperosmolality in small infants due to propylene glycol. Pediatrics. 1983;72:353-355
12. MacDonald MG, Getson PR, Glasgo AM, Miller MK, Boechx RL, Johnson EL. Propylene glycol: increase incidence of seizures in low birth weight infants. Pediatrics. 1987;79:622-625
13. Lovejoy FH. Fatal benzyl alcohol poisoning in neonatal intensive care units. A new concern for pediatricians. Am J Dis Child. 1982;136:974-975
14. Menon PA, Thach BT, Smith CH, et al. Benzyl alcohol toxicity in neonatal intensive care unit. Incidence, symptomatology and mortality. Am J Perinatol. 1984;1:288-292
15. Stewart CF, Hampton EM. Effect of maturation on drug disposition in pediatric patients. Clin Pharmacol. 1987;6:548-564
16. Painter MJ, Pippenger C, MacDonald H, Pitlick W. Phenobarbital and diphenylhydantoin levels in neonates with seizures. J Pediatr. 1978;92: 315-319
17. Signer E, Fridrich R. Gastric emptying in newborns and young infants. Acta Pediatr Scand. 1975;64:525-530
18. Assael BM. Pharmacokinetics and drug disposition during postnatal development. Pharmacol Ther. 1982;18:159-197
19. Rane A. Drug disposition and action in infants and children. In: Yaffe SJ, Aranda JV, eds. Pediatric Pharmacology. Therapeutics Principles in Practice. New York, NY: WB Saunders; 1992;10-21
20. Arant BS. Developmental patterns of renal function maturation compared in the neonate. J Pediatr. 1978;92:705-712
21. Phelps SJ, Hak EB. Guidelines for Administration of Intravenous Medications to Pediatric Patients. Bethesda, MD: American Society of Health-System Pharmacists; 1996
22. Park MK. Use of digoxin in infants and children with specific emphasis on dosage. J Pediatr. 1986;108:871-877
23. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials: a survey of three medical journals. N Engl J Med. 1987; 317:426-432
24. Williamson JW, Goldschmidt PG, Colton T. The quality of medical literature. An analysis of validation assessments. In: Bailar JC, Mosterller F, eds. Medical Uses of Statistics. Boston, MA: Massachusetts Medical Society; 1986:370-391
25. Meinert CL, Tonascia S, Higgins K. Content of reports on clinical trials. A critical review. Controlled Clin Trials. 1984;5:328-347
26. Bland JM, Jones DR, Bennett S, Cook DG, Haines AP, MacFarlane AJ. Is the clinical trial evidence about new drugs statistically adequate? Br J Clin Pharmacol. 1985;19:155-160
27. Shirkey H. Therapeutic orphans. J Pediatr. 1968;72:119-120. Editorial
28. New Medicines in Development for Children. Washington, DC: Pharmaceutical Research and Manufacturers of America; 1997